281 related articles for article (PubMed ID: 26255682)
1. Bone biology, signaling pathways, and therapeutic targets for osteoporosis.
Iñiguez-Ariza NM; Clarke BL
Maturitas; 2015 Oct; 82(2):245-55. PubMed ID: 26255682
[TBL] [Abstract][Full Text] [Related]
2. Treatment of post-menopausal osteoporosis: beyond bisphosphonates.
Ishtiaq S; Fogelman I; Hampson G
J Endocrinol Invest; 2015 Jan; 38(1):13-29. PubMed ID: 25194424
[TBL] [Abstract][Full Text] [Related]
3. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
Gallacher SJ; Dixon T
Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)].
Quemerais-Durieu MA; Kerlan V; Chabre O
Ann Endocrinol (Paris); 2011 Oct; 72 Suppl 1():S15-22. PubMed ID: 22008272
[TBL] [Abstract][Full Text] [Related]
5. Drug-Related Adverse Events of Osteoporosis Therapy.
Khan M; Cheung AM; Khan AA
Endocrinol Metab Clin North Am; 2017 Mar; 46(1):181-192. PubMed ID: 28131131
[TBL] [Abstract][Full Text] [Related]
6. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
7. How to manage postmenopausal osteoporosis?
Body JJ
Acta Clin Belg; 2011; 66(6):443-7. PubMed ID: 22338309
[TBL] [Abstract][Full Text] [Related]
8. Teriparatide and denosumab combination therapy and skeletal metabolism.
Idolazzi L; Rossini M; Viapiana O; Braga V; Fassio A; Benini C; Kunnathully V; Adami S; Gatti D
Osteoporos Int; 2016 Nov; 27(11):3301-3307. PubMed ID: 27250971
[TBL] [Abstract][Full Text] [Related]
9. Osteoporosis treatment and prevention for postmenopausal women: current and future therapeutic options.
Pinkerton JV; Thomas S; Dalkin AC
Clin Obstet Gynecol; 2013 Dec; 56(4):711-21. PubMed ID: 24100598
[TBL] [Abstract][Full Text] [Related]
10. THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis.
Anastasilakis AD; Polyzos SA; Makras P
Eur J Endocrinol; 2018 Jul; 179(1):R31-R45. PubMed ID: 29691303
[TBL] [Abstract][Full Text] [Related]
11. New therapeutic targets for osteoporosis: beyond denosumab.
Lim V; Clarke BL
Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
[TBL] [Abstract][Full Text] [Related]
12. Using Osteoporosis Therapies in Combination.
McClung MR
Curr Osteoporos Rep; 2017 Aug; 15(4):343-352. PubMed ID: 28667435
[TBL] [Abstract][Full Text] [Related]
13. Combined Pharmacologic Therapy in Postmenopausal Osteoporosis.
Shen Y; Gray DL; Martinez DS
Endocrinol Metab Clin North Am; 2017 Mar; 46(1):193-206. PubMed ID: 28131133
[TBL] [Abstract][Full Text] [Related]
14. Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.
Dempster DW; Zhou H; Recker RR; Brown JP; Recknor CP; Lewiecki EM; Miller PD; Rao SD; Kendler DL; Lindsay R; Krege JH; Alam J; Taylor KA; Janos B; Ruff VA
J Clin Endocrinol Metab; 2016 Apr; 101(4):1353-63. PubMed ID: 26859106
[TBL] [Abstract][Full Text] [Related]
15. One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.
Reyes C; Tebe C; Martinez-Laguna D; Ali MS; Soria-Castro A; Carbonell C; Prieto-Alhambra D
Osteoporos Int; 2017 Oct; 28(10):2997-3004. PubMed ID: 28714038
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Uebelhart D; Frey D; Frey-Rindova P; Goerres G; Michel BA
Z Rheumatol; 2003 Dec; 62(6):512-7. PubMed ID: 14685711
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological management of osteogenesis.
Nardone V; D'Asta F; Brandi ML
Clinics (Sao Paulo); 2014 Jun; 69(6):438-46. PubMed ID: 24964310
[TBL] [Abstract][Full Text] [Related]
18. Treatment needs and current options for postmenopausal osteoporosis.
Gennari L; Rotatori S; Bianciardi S; Nuti R; Merlotti D
Expert Opin Pharmacother; 2016 Jun; 17(8):1141-52. PubMed ID: 27055223
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis: now and the future.
Rachner TD; Khosla S; Hofbauer LC
Lancet; 2011 Apr; 377(9773):1276-87. PubMed ID: 21450337
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of denosumab for the treatment of osteoporosis: A systematic review.
Diédhiou D; Cuny T; Sarr A; Norou Diop S; Klein M; Weryha G
Ann Endocrinol (Paris); 2015 Dec; 76(6):650-7. PubMed ID: 26639186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
